We are live on ! Find out more
CFB

Cullen/Frost Bankers Portfolio holdings

AUM $10.1B
1-Year Est. Return 29.18%
This Fund
S&P 500
This Quarter Est. Return
+8.71%
1 Year Est. Return
+29.18%
3 Year Est. Return
+91.06%
5 Year Est. Return
+115.39%
10 Year Est. Return
+478.9%
AUM
$3.66B
AUM Growth
+$288M
Cap. Flow
+$21M
Cap. Flow %
0.57%
Top 10 Hldgs %
22.73%
Holding
1,119
New
113
Increased
294
Reduced
320
Closed
71

Top Buys

Rank Stock Value
1
NKE icon
Nike
NKE
+$9.8M
2
BMY icon
Bristol-Myers Squibb
BMY
+$7.08M
3
PM icon
Philip Morris
PM
+$4.77M
4
STZ icon
Constellation Brands
STZ
+$4.29M
5
PB icon
Prosperity Bancshares
PB
+$4.21M

Sector Composition

Rank Sector Weight
1 Technology 15.63%
2 Financials 15.05%
3 Healthcare 11.78%
4 Consumer Discretionary 10.36%
5 Communication Services 8.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BRO icon
576
Brown & Brown
BRO
$24B
$56K ﹤0.01%
1,424
+539
+61% +$20.2K
KSS icon
577
Kohl's
KSS
$2.22B
$56K ﹤0.01%
1,100
-7,235
-87% -$368K
PAGS icon
578
PagSeguro Digital
PAGS
$2.43B
$56K ﹤0.01%
1,653
+1,357
+458% +$48.8K
PH icon
579
Parker-Hannifin
PH
$134B
$56K ﹤0.01%
270
-146
-35% -$28.3K
UTG icon
580
Reaves Utility Income Fund
UTG
$3.69B
$56K ﹤0.01%
1,500
PDCO
581
DELISTED
Patterson Companies, Inc.
PDCO
$56K ﹤0.01%
2,745
STXB
582
DELISTED
Spirit of Texas Bancshares, Inc. Common Stock
STXB
$56K ﹤0.01%
2,415
BMY.RT
583
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
$56K ﹤0.01%
+18,602
New +$48.4K
IEMG icon
584
iShares Core MSCI Emerging Markets ETF
IEMG
$159B
$55K ﹤0.01%
1,015
-392
-28% -$20.2K
USCI icon
585
US Commodity Index
USCI
$374M
$55K ﹤0.01%
1,500
DLN icon
586
WisdomTree US LargeCap Dividend Fund
DLN
$6.45B
$53K ﹤0.01%
996
BND icon
587
Vanguard Total Bond Market
BND
$162B
$52K ﹤0.01%
619
+12
+2% +$1.01K
CIEN icon
588
Ciena
CIEN
$62.7B
$52K ﹤0.01%
1,208
-378
-24% -$14.4K
SPH icon
589
Suburban Propane Partners
SPH
$1.17B
$51K ﹤0.01%
2,330
-825
-26% -$18.9K
GAP
590
The Gap Inc
GAP
$7.34B
$51K ﹤0.01%
+2,900
New +$49.4K
BIO icon
591
Bio-Rad Laboratories Class A
BIO
$9.66B
$50K ﹤0.01%
136
+73
+116% +$25.7K
CMS icon
592
CMS Energy
CMS
$22.1B
$50K ﹤0.01%
+800
New +$49.9K
SLV icon
593
iShares Silver Trust
SLV
$31.3B
$50K ﹤0.01%
2,992
IAA
594
DELISTED
IAA, Inc. Common Stock
IAA
$50K ﹤0.01%
1,052
+461
+78% +$19.4K
JRO
595
DELISTED
Nuveen Floating Rate Income Opportunty Fund
JRO
$50K ﹤0.01%
5,000
RSG icon
596
Republic Services
RSG
$65.9B
$49K ﹤0.01%
543
-220
-29% -$19.2K
EMN icon
597
Eastman Chemical
EMN
$8.43B
$48K ﹤0.01%
+600
New +$46.1K
INDA icon
598
iShares MSCI India ETF
INDA
$6.58B
$48K ﹤0.01%
1,365
TCF
599
DELISTED
TCF Financial Corporation Common Stock
TCF
$48K ﹤0.01%
1,016
IPG
600
DELISTED
Interpublic Group of Companies
IPG
$47K ﹤0.01%
2,029
+1,325
+188% +$29.1K

Similar funds

Cullen/Frost Bankers's Q4 2019 Portfolio in Review

As of Q4 2019, Cullen/Frost Bankers held 1,119 positions worth $3.66B, up 8.5% from $3.37B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Cullen/Frost Bankers's Q4 2019 filing shows 113 new, 294 increased, 320 reduced and 71 closed positions. Its largest new stake was Albemarle: 6,600 shares worth $482K. The largest sale was Ulta Beauty, an estimated $7.43M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.

  • Cullen/Frost Bankers's largest Q4 2019 buy was Albemarle: 6,600 shares worth $482K.
  • Cullen/Frost Bankers added most to Nike in Q4 2019, an estimated $9.8M increase.
  • Cullen/Frost Bankers's biggest Q4 2019 reduction was Ulta Beauty, cutting an estimated $7.43M.
  • Cullen/Frost Bankers fully exited LegacyTexas Financial Group Inc in Q4 2019, selling an estimated $4.88M.
  • Cullen/Frost Bankers's ten largest holdings make up 23% of its $3.66B portfolio in Q4 2019.
  • Cullen/Frost Bankers opened 113 new positions and closed 71 in Q4 2019.
  • Cullen/Frost Bankers's portfolio value rose 8.5% quarter-over-quarter to $3.66B.

Based on Cullen/Frost Bankers's 13F filing for Q4 2019, filed 6 Feb 2020.